AstraZeneca PLC is 1.4x more valuable than Novo Nordisk A/S by market capitalization ($286.27 B vs $202.94 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NVO | AZN |
|---|---|---|
| Market cap | $202.94 B | $286.27 B |
| US-listed rank | #67 | #45 |
| SEC filings | 998 | 1,004 |
AstraZeneca PLC is 1.4x more valuable than Novo Nordisk A/S by market capitalization ($286.27 B vs $202.94 B).
Full pages: Novo Nordisk A/S and AstraZeneca PLC, or browse the full rankings.